SUFU (C54G2) Rabbit mAbProduct information
|100 µl (10 western blots)||-||Unavailable in your region|
Product Pathways - Development
SUFU (C54G2) Rabbit mAb #2520
|2520S||100 µl (10 western blots)||---||In Stock||---|
|2520||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||54||Rabbit IgG|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
SUFU (C54G2) Rabbit mAb detects endogenous level of total SUFU protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu458 of human SUFU.
SUFU (Suppressor of Fused) was identified in Drosophila as a suppressor of the Fused (Fu) kinase that is essential for Hedgehog signaling during embryonic pattern formation (1). SUFU suppresses Hedgehog signaling by regulating the localization of the transcription factors Gli and Ci (2,3). In Drosophila, SUFU may also positively regulate Hedgehog signaling depending on SUFU protein levels and Hedgehog signal intensity (4). SUFU may function as a tumor suppressor as inactivation and loss of heterozygosity of SUFU is associated with human rhabdomyosarcomas and medulloblastomas (5,6). Deletion of SUFU in mice results in embryonic lethality, while heterozygotes exhibit developmental defects characteristic of basal cell nevus syndrome. This aberrant developmental pathway is attributed to ligand-independent activation of Hedgehog signaling (7). GSK-3β binds and phosphorylates SUFU in vitro and additional information predicts that GSK-3β may positively regulate Hedgehog signaling through modification of SUFU (8).
- Pham, A. et al. (1995) Genetics 140, 587-598.
- Barnfield, P.C. et al. (2005) Differentiation 73, 397-405.
- Méthot, N. and Basler, K. (2000) Development 127, 4001-4010.
- Dussillol-Godar, F. et al. (2006) Dev. Biol. 291, 53-66.
- Tostar, U. et al. (2006) J. Pathol. 208, 17-25.
- Taylor, M.D. et al. (2002) Nat. Genet. 31, 306-310.
- Svärd, J. et al. (2006) Dev. Cell. 10, 187-197.
- Takenaka, K. et al. (2007) Biochem. Biophys. Res. Commun. 353, 501-508.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 2553 GLI1 Antibody
- 2470 PTCH2 (G1191) Antibody
- 2464 PTCH2 (L849) Antibody
- 2287 Shh Antibody
- 2271 Shh/Ihh Antibody
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
U.S. Patent No. 5,675,063.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.